Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.48 USD | +1.64% | -0.80% | -0.80% |
04-25 | OncoCyte Corporation announced that it has received $15.8 million in funding | CI |
04-16 | Broadwood Capital, Inc. Engages with OncoCyte Corporation | CI |
Evolution of the average Target Price on OncoCyte Corporation
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering OncoCyte Corporation
Needham & Co. | |
Benchmark Company | |
Piper Sandler | |
Lake Street | |
Stephens Inc. | |
KeyBanc Capital Markets | |
Chardan |
EPS Revisions
- Stock Market
- Equities
- OCX Stock
- Consensus OncoCyte Corporation